Macrophage lineages in heart valve development and disease

Lavine, 2018, The macrophage in cardiac homeostasis and disease: JACC macrophage in CVD series (part 4), J Am Coll Cardiol, 72, 2213, 10.1016/j.jacc.2018.08.2149

Ridker, 2017, Antiinflammatory therapy with canakinumab for atherosclerotic disease, N Engl J Med, 377, 1119, 10.1056/NEJMoa1707914

Nasir, 2008, Ethnic differences between extra-coronary measures on cardiac computed tomography: multi-ethnic study of atherosclerosis (MESA), Atherosclerosis, 198, 104, 10.1016/j.atherosclerosis.2007.09.008

Iung, 2011, Epidemiology of valvular heart disease in the adult, Nat Rev Cardiol, 8, 162, 10.1038/nrcardio.2010.202

Levine, 2015, Mitral valve disease–morphology and mechanisms, Nat Rev Cardiol, 12, 689, 10.1038/nrcardio.2015.161

Lindman, 2016, Calcific aortic stenosis, Nat Rev Dis Primers, 2, 16006, 10.1038/nrdp.2016.6

Nishimura, 2017, 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 135, e1159, 10.1161/CIR.0000000000000503

Visconti, 2006, An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells, Circ Res, 98, 690, 10.1161/01.RES.0000207384.81818.d4

Hajdu, 2011, Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic process, J Mol Cell Cardiol, 51, 955, 10.1016/j.yjmcc.2011.08.006

Hulin, 2018, Macrophage transitions in heart valve development and myxomatous valve disease, Arterioscler Thromb Vasc Biol, 38, 636, 10.1161/ATVBAHA.117.310667

Hulin, 2019, Maturation of heart valve cell populations during postnatal remodeling, Development, 146, 10.1242/dev.173047

Anstine, 2017, Contribution of extra-cardiac cells in murine heart valves is age-dependent, J Am Heart Assoc, 6, 10.1161/JAHA.117.007097

Hulin, 2017, Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease, Cardiovasc Res, 113, 40, 10.1093/cvr/cvw229

Shigeta, 2019, Endocardially derived macrophages are essential for valvular remodeling, Dev Cell, 48, 617, 10.1016/j.devcel.2019.01.021

Cavaillon, 2011, The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff, J Leukoc Biol, 90, 413, 10.1189/jlb.0211094

Ginhoux, 2016, Tissue-resident macrophage ontogeny and homeostasis, Immunity, 44, 439, 10.1016/j.immuni.2016.02.024

Davies, 2013, Tissue-resident macrophages, Nat Immunol, 14, 986, 10.1038/ni.2705

Williams, 2018, Macrophage biology, classification, and phenotype in cardiovascular disease: JACC macrophage in CVD series (part 1), J Am Coll Cardiol, 72, 2166, 10.1016/j.jacc.2018.08.2148

Nahrendorf, 2016, Abandoning M1/M2 for a network model of macrophage function, Circ Res, 119, 414, 10.1161/CIRCRESAHA.116.309194

Schulz, 2012, A lineage of myeloid cells independent of Myb and hematopoietic stem cells, Science, 336, 86, 10.1126/science.1219179

Epelman, 2014, Origin and functions of tissue macrophages, Immunity, 41, 21, 10.1016/j.immuni.2014.06.013

Medvinsky, 1996, Definitive hematopoiesis is autonomously initiated by the AGM region, Cell, 86, 897, 10.1016/S0092-8674(00)80165-8

Yona, 2013, Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis, Immunity, 38, 79, 10.1016/j.immuni.2012.12.001

Epelman, 2014, Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation, Immunity, 40, 91, 10.1016/j.immuni.2013.11.019

Medvinsky, 2011, Embryonic origin of the adult hematopoietic system: advances and questions, Development, 138, 1017, 10.1242/dev.040998

Pinto, 2016, Revisiting cardiac cellular composition, Circ Res, 118, 400, 10.1161/CIRCRESAHA.115.307778

Heidt, 2014, Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction, Circ Res, 115, 284, 10.1161/CIRCRESAHA.115.303567

Lavine, 2014, Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart, Proc Natl Acad Sci USA, 111, 16029, 10.1073/pnas.1406508111

Kruithof, 2020, Stress-induced remodelling of the mitral valve: a model for leaflet thickening and superimposed tissue formation in mitral valve disease, Cardiovasc Res, 116, 931

Leid, 2016, Primitive embryonic macrophages are required for coronary development and maturation, Circ Res, 118, 1498, 10.1161/CIRCRESAHA.115.308270

Aurora, 2014, Macrophages are required for neonatal heart regeneration, J Clin Invest, 124, 1382, 10.1172/JCI72181

Hulsmans, 2017, Macrophages facilitate electrical conduction in the heart, Cell, 169, 510, 10.1016/j.cell.2017.03.050

Bajpai, 2018, The human heart contains distinct macrophage subsets with divergent origins and functions, Nat Med, 24, 1234, 10.1038/s41591-018-0059-x

Dewald, 2005, CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts, Circ Res, 96, 881, 10.1161/01.RES.0000163017.13772.3a

Bajpai, 2019, Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury, Circ Res, 124, 263, 10.1161/CIRCRESAHA.118.314028

Sager, 2016, Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure, Circ Res, 119, 853, 10.1161/CIRCRESAHA.116.309001

Majmudar, 2013, Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice, Circulation, 127, 2038, 10.1161/CIRCULATIONAHA.112.000116

Nahrendorf, 2018, Myeloid cell contributions to cardiovascular health and disease, Nat Med, 24, 711, 10.1038/s41591-018-0064-0

Schoen, 2012, Mechanisms of function and disease of natural and replacement heart valves, Annu Rev Pathol, 7, 161, 10.1146/annurev-pathol-011110-130257

Hinton, 2006, Extracellular matrix remodeling and organization in developing and diseased aortic valves, Circ Res, 98, 1431, 10.1161/01.RES.0000224114.65109.4e

Mahler, 2014, Effects of shear stress pattern and magnitude on mesenchymal transformation and invasion of aortic valve endothelial cells, Biotechnol Bioeng, 111, 2326, 10.1002/bit.25291

Hinton, 2011, Heart valve structure and function in development and disease, Annu Rev Physiol, 73, 29, 10.1146/annurev-physiol-012110-142145

Choi, 2009, Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves, J Exp Med, 206, 497, 10.1084/jem.20082129

Kim, 2020, Deficiency of circulating monocytes ameliorates the progression of myxomatous valve degeneration in Marfan syndrome, Circulation, 141, 132, 10.1161/CIRCULATIONAHA.119.042391

Combs, 2009, Heart valve development: regulatory networks in development and disease, Circ Res, 105, 408, 10.1161/CIRCRESAHA.109.201566

de Lange, 2004, Lineage and morphogenetic analysis of the cardiac valves, Circ Res, 95, 645, 10.1161/01.RES.0000141429.13560.cb

Lincoln, 2004, Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos, Dev Dyn, 230, 239, 10.1002/dvdy.20051

Nakano, 2013, Haemogenic endocardium contributes to transient definitive haematopoiesis, Nat Commun, 4, 1564, 10.1038/ncomms2569

Aikawa, 2006, Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering, Circulation, 113, 1344, 10.1161/CIRCULATIONAHA.105.591768

Wang, 2017, Notch-Tnf signalling is required for development and homeostasis of arterial valves, Eur Heart J, 38, 675

Gottlieb Sen, 2018, The transcriptional signature of growth in human fetal aortic valve development, Ann Thorac Surg, 106, 1834, 10.1016/j.athoracsur.2018.06.034

Molawi, 2014, Progressive replacement of embryo-derived cardiac macrophages with age, J Exp Med, 211, 2151, 10.1084/jem.20140639

Geirsson, 2012, Modulation of transforming growth factor-beta signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers, Circulation, 126, S189–S, 10.1161/CIRCULATIONAHA.111.082610

Yutzey, 2014, Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease, Arterioscler Thromb Vasc Biol, 34, 2387, 10.1161/ATVBAHA.114.302523

Guauque-Olarte, 2016, RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing, Physiol Genomics, 48, 749, 10.1152/physiolgenomics.00041.2016

Raddatz, 2019, Adaptive immune cells in calcific aortic valve disease, Am J Physiol Heart Circ Physiol, 317, H141, 10.1152/ajpheart.00100.2019

Li, 2017, The shift of macrophages toward M1 phenotype promotes aortic valvular calcification, J Thorac Cardiovasc Surg, 153, 1318, 10.1016/j.jtcvs.2017.01.052

Nkomo, 2006, Burden of valvular heart diseases: a population-based study, Lancet, 368, 1005, 10.1016/S0140-6736(06)69208-8

Enriquez-Sarano, 2005, Quantitative determinants of the outcome of asymptomatic mitral regurgitation, N Engl J Med, 352, 875, 10.1056/NEJMoa041451

Rabkin, 2001, Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves, Circulation, 104, 2525, 10.1161/hc4601.099489

Gupta, 2009, Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves, Cardiovasc Pathol, 18, 191, 10.1016/j.carpath.2008.05.001

Akhtar, 1999, Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae, Cardiovasc Pathol, 8, 191, 10.1016/S1054-8807(99)00004-6

Rabkin-Aikawa, 2004, Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves, J Heart Valve Dis, 13, 841

Grande-Allen, 2003, Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations, J Am Coll Cardiol, 42, 271, 10.1016/S0735-1097(03)00626-0

Meier, 2018, CD301b/MGL2(+) mononuclear phagocytes orchestrate autoimmune cardiac valve inflammation and fibrosis, Circulation, 137, 2478, 10.1161/CIRCULATIONAHA.117.033144

Judge, 2011, Mitral valve disease in Marfan syndrome and related disorders, J Cardiovasc Transl Res, 4, 741, 10.1007/s12265-011-9314-y

Le Tourneau, 2018, Genetics of syndromic and non-syndromic mitral valve prolapse, Heart, 104, 978, 10.1136/heartjnl-2017-312420

Atzinger, 2011, Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic Ehlers-Danlos syndrome, J Pediatr, 158, 826, 10.1016/j.jpeds.2010.11.023

Baasanjav, 2011, Faulty initiation of proteoglycan synthesis causes cardiac and joint defects, Am J Hum Genet, 89, 15, 10.1016/j.ajhg.2011.05.021

Loeys, 2005, A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2, Nat Genet, 37, 275, 10.1038/ng1511

Andrabi, 2011, SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction, Am J Med Genet A, 155A, 1165, 10.1002/ajmg.a.33968

van der Linde, 2012, Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants, J Am Coll Cardiol, 60, 397, 10.1016/j.jacc.2011.12.052

Sauls, 2012, Developmental basis for filamin-A-associated myxomatous mitral valve disease, Cardiovasc Res, 96, 109, 10.1093/cvr/cvs238

Lardeux, 2011, Filamin-a-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects, J Cardiovasc Transl Res, 4, 748, 10.1007/s12265-011-9308-9

Le Tourneau, 2018, New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study, Eur Heart J, 39, 1269, 10.1093/eurheartj/ehx505

Sauls, 2015, Increased infiltration of extra-cardiac cells in myxomatous valve disease, J Cardiovasc Dev Dis, 2, 200, 10.3390/jcdd2030200

Kim, 2019, Endothelial cell lineage analysis does not provide evidence for EMT in adult valve homeostasis and disease, Anat Rec (Hoboken, 302, 125, 10.1002/ar.23916

Bartko, 2017, Effect of losartan on mitral valve changes after myocardial infarction, J Am Coll Cardiol, 70, 1232, 10.1016/j.jacc.2017.07.734

Bischoff, 2016, CD45 expression in mitral valve endothelial cells after myocardial infarction, Circ Res, 119, 1215, 10.1161/CIRCRESAHA.116.309598

Wight, 2014, Versican and the control of inflammation, Matrix Biol, 35, 152, 10.1016/j.matbio.2014.01.015

Lu, 2015, Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study, Vet J, 204, 23, 10.1016/j.tvjl.2015.02.021

Thalji, 2015, Nonbiased molecular screening identifies novel molecular regulators of fibrogenic and proliferative signaling in myxomatous mitral valve disease, Circ Cardiovasc Genet, 8, 516, 10.1161/CIRCGENETICS.114.000921

Ng, 2004, TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome, J Clin Invest, 114, 1586, 10.1172/JCI200422715

Hulin, 2012, Metallothionein-dependent up-regulation of TGF-beta2 participates in the remodelling of the myxomatous mitral valve, Cardiovasc Res, 93, 480, 10.1093/cvr/cvr337

Petrey, 2014, Hyaluronan, a crucial regulator of inflammation, Front Immunol, 5, 101, 10.3389/fimmu.2014.00101

Lincoln, 2014, Etiology of valvular heart disease-genetic and developmental origins, Circ J, 78, 1801, 10.1253/circj.CJ-14-0510

Maganti, 2010, Valvular heart disease: diagnosis and management, Mayo Clin Proc, 85, 483, 10.4065/mcp.2009.0706

Shen, 2013, Processes of sterile inflammation, J Immunol, 191, 2857, 10.4049/jimmunol.1301539

Noels, 2019, Chemokines as therapeutic targets in cardiovascular disease, Arterioscler Thromb Vasc Biol, 39, 583, 10.1161/ATVBAHA.118.312037

Leuschner, 2011, Therapeutic siRNA silencing in inflammatory monocytes in mice, Nat Biotechnol, 29, 1005, 10.1038/nbt.1989

Nahrendorf, 2010, Monocytes: protagonists of infarct inflammation and repair after myocardial infarction, Circulation, 121, 2437, 10.1161/CIRCULATIONAHA.109.916346

Vagnozzi, 2020, An acute immune response underlies the benefit of cardiac stem cell therapy, Nature, 577, 405, 10.1038/s41586-019-1802-2

Struthers, 2010, CCR2 antagonists, Curr Top Med Chem, 10, 1278, 10.2174/156802610791561255

Zheng, 2016, Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists, Nature, 540, 458, 10.1038/nature20605

Taylor, 2019, Structural basis for ligand modulation of the CCR2 conformational landscape, Proc Natl Acad Sci USA, 116, 8131, 10.1073/pnas.1814131116